Price to Book Value of Argenx S.E

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Price to Book Value analysis of Argenx S.E


 Price EUR  143.60
 Book Value per share EUR  12.60
 Capitalization (mn) EUR  6,133
 Total Book Value (mn) EUR  542
 P/BV ratio 11.40
 Argenx S.E dividend
 Argenx S.E Price to Cash-Flow
 Argenx S.E Price to earnings
 Argenx S.E Return on Equity

Argenx S.E is a Health Care industry firm, which focus his business in Pharmaceuticals and Biotechnology sector. Argenx S.E offices are placed in Belgium and Lux., where the firm is traded.

At the date of this study, Argenx S.E shares were being negotiated at a price of 143.60 EUR after 0.00% from the beginning of the year.

According to the chart displayed below, Argenx S.E Price to Book Value Ratio is 11.40, bigger than the amount offered by both firms from Belgium and Lux. and fromPharmaceuticals and Biotechnology sector. This high P/BV might be a sign of a overvalued company, but also a healthy sign because the market expects growing profits in the near future for the same book value (originally invested). However, it is necessary to study Argenx S.E financial situation to reach such a strong conclussion.

Finally, you could draw a comparisson Argenx S.E P/BV with other Pharmaceuticals and Biotechnology companies or firms from Belgium and Lux..

Argenx S.E price to book value

Next companies

Ariake Japan. Japan. Consumer Goods.

Arista Networks. USA. Technology.

Aristocrat Leisure. Australia. Consumer Services.

Arkema. France. Basic Materials.

Aroundtown SA. Germany. Financials.

Arrow Electronics. USA. Industrials.

Previous companies

Arconic. USA. Basic Materials.

Archer Daniels Mid.. USA. Consumer Goods.

Arch Capital Gp. USA. Financials.

Arcelor Mittal. Netherlands. Basic Materials.

Arcelik. Turkey. Consumer Goods.

Arca Continental SAB. Mexico. Consumer Goods.

All rights reserved

 information advertisement legal

Dividends Ranking | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.